(CME) CME - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US12572Q1058
CME: Futures, Options, Commodities, Securities, Data, Clearing
CME Group Inc. stands as a titan in the financial derivatives sector, operating some of the globes most substantial futures and options contract markets. As one of the largest derivatives exchanges, it provides a vast array of products spanning interest rates, equity indexes, foreign exchange, agricultural commodities, energy, metals, and more. This extensive offerings allow for precise risk management and investment strategies across various asset classes.
Headquartered in Chicago, CME Groups legacy traces back to 1898, evolving from the Chicago Mercantile Exchange. Its services extend beyond trading, encompassing critical functions like clearing, settling, and guaranteeing contracts. This role is vital for maintaining market integrity and facilitating smooth transactions. Additionally, the company offers trade processing and risk mitigation services, essential for institutional risk management.
CME Group serves a diverse clientele, including professional traders, financial institutions, and institutional investors. Corporations, governments, and central banks also rely on their services for hedging and investment purposes. Their market data services provide real-time and historical data, crucial for informed decision-making in trading and analysis.
Financially, CME Group boasts a market capitalization of over $90 billion, with key metrics including a P/E ratio of approximately 25.89 and a forward P/E of 23.81. These figures underscore its stability and growth prospects in the financial sector. For more details, visit their website at https://www.cmegroup.com.
Additional Sources for CME Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CME Stock Overview
Market Cap in USD | 91,449m |
Sector | Financial Services |
Industry | Financial Data & Stock Exchanges |
GiC Sub-Industry | Financial Exchanges & Data |
IPO / Inception | 2002-12-06 |
CME Stock Ratings
Growth 5y | 74.8% |
Fundamental | 72.6% |
Dividend | 76.2% |
Rel. Strength Industry | 2.2 |
Analysts | 3.33/5 |
Fair Price Momentum | 282.04 USD |
Fair Price DCF | 230.62 USD |
CME Dividends
Dividend Yield 12m | 4.48% |
Yield on Cost 5y | 8.67% |
Annual Growth 5y | 12.00% |
Payout Consistency | 95.5% |
CME Growth Ratios
Growth Correlation 3m | 91.1% |
Growth Correlation 12m | 83.5% |
Growth Correlation 5y | 74.3% |
CAGR 5y | 16.35% |
CAGR/Max DD 5y | 0.52 |
Sharpe Ratio 12m | 1.56 |
Alpha | 19.81 |
Beta | -0.10 |
Volatility | 18.90% |
Current Volume | 1935.7k |
Average Volume 20d | 2144.6k |
As of March 16, 2025, the stock is trading at USD 258.68 with a total of 1,935,748 shares traded.
Over the past week, the price has changed by +1.61%, over one month by +5.90%, over three months by +12.93% and over the past year by +23.36%.
Yes, based on ValueRay Fundamental Analyses, CME (NASDAQ:CME) is currently (March 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 72.64 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CME as of March 2025 is 282.04. This means that CME is currently overvalued and has a potential downside of 9.03%.
CME has received a consensus analysts rating of 3.33. Therefor, it is recommend to hold CME.
- Strong Buy: 4
- Buy: 1
- Hold: 10
- Sell: 3
- Strong Sell: 0
According to ValueRays Forecast Model, CME CME will be worth about 304.6 in March 2026. The stock is currently trading at 258.68. This means that the stock has a potential upside of +17.75%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 254.6 | -1.6% |
Analysts Target Price | 242.4 | -6.3% |
ValueRay Target Price | 304.6 | 17.8% |